SRC and Lewy body dementia: Bosutinib, an Abl/Src inhibitor, reduces pathological markers and improves activities of daily living in patients diagnosed with Dementia with Lewy Bodies (DLB) (Hebron et al, 2013b, 2014; Mahul-Mellier et al, 2014; Lonskaya et al, 2015; Javidnia et al, 2017; Pagan et al, 2022).